AUNIP as a marker for cervical cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study is looking for a new marker in the blood that could help detect cervical cancer. They will compare levels of a protein called AUNIP in women with cervical cancer versus healthy women.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between the ages of 20 and 60.
- You have been diagnosed with cervical cancer (confirmed by a biopsy).
- You do not have other tumors or growths in your uterus or nearby structures.
- If you are healthy (without cervical cancer), you must have no other tumors, no inflammatory conditions, and normal blood test results.
- If you are healthy, you cannot be pregnant, breastfeeding, or currently receiving the HPV vaccine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at ways to improve cervical cancer screening for women. If you join, you may help researchers find better methods for early detection, which can lead to earlier treatment and better outcomes.
This trial checks how well cervical cancer responds to surgery, radiation, and chemotherapy by measuring HPV DNA and RNA in blood and cervical mucus. It aims to improve monitoring during treatment.
This study checks whether “liquid biopsies” (blood tests that look for cancer-related signals) can help monitor how HPV-related cancers respond to treatment. It may help doctors spot changes earlier during care.
This study compares different ways to screen for cervical cancer in women living with HIV. It aims to find the most effective and practical screening approach for this group.
This study tests whether DNA found in blood and urine can help detect cervical cancer and monitor it after treatment. If you’re newly diagnosed, these minimally invasive samples may help doctors follow your disease more easily over time.
This study tests a new technology to help find cervical cancer earlier by focusing on people who already had an abnormal screening result. It may help improve how abnormal tests are checked and diagnosed.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.